Literature DB >> 21987045

Five-year results of a randomized clinical trial on treatment in Dupuytren's disease: percutaneous needle fasciotomy versus limited fasciectomy.

Annet L van Rijssen1, Hein Ter Linden, Paul M N Werker.   

Abstract

BACKGROUND: The increasing number of methods for treating Dupuytren's disease indicates a need for comparative studies. In this article, the 5-year follow-up results of a randomized controlled study that compared percutaneous needle fasciotomy and limited fasciectomy are presented.
METHODS: One hundred eleven patients with 115 affected hands with a minimal passive extension deficit of 30 degrees were assigned randomly to the two groups. Follow-up examinations were performed at 1 and 6 weeks; 6 months; and 1, 2, 3, 4, and 5 years. Outcome parameters were total passive extension deficit, patient satisfaction, flexion, and sensibility. Furthermore, disease extension was recorded. The primary endpoint was recurrence, defined as an increase of total passive extension deficit of greater than 30 degrees. Ninety-three patients reached this endpoint.
RESULTS: The recurrence rate after 5 years in the needle fasciotomy group (84.9 percent) was significantly higher than in the limited fasciectomy group (20.9 percent) (p < 0.001), and occurred significantly sooner in the needle fasciotomy group (p = 0.001). Older age at the time of treatment decreased the recurrence rate (p = 0.005). No other diathesis characteristics influenced recurrence. Patient satisfaction was high in both groups but was significantly higher in the limited fasciectomy group. Nevertheless, many patients (53 percent) preferred percutaneous needle fasciotomy in case of recurrence.
CONCLUSIONS: Percutaneous needle fasciotomy is the preferred treatment for elderly patients with Dupuytren's disease and for those willing to accept a possible early recurrence in the context of the advantages, such as fast recovery, a low complication rate, and minimal invasiveness. CLINICAL QUESTION/LEVEL OF EVIDENCE: Therapeutic, II.

Entities:  

Mesh:

Year:  2012        PMID: 21987045     DOI: 10.1097/PRS.0b013e31823aea95

Source DB:  PubMed          Journal:  Plast Reconstr Surg        ISSN: 0032-1052            Impact factor:   4.730


  66 in total

Review 1.  Trends in the Treatment of Dupuytren Disease in the United States Between 2007 and 2014.

Authors:  Marc D Lipman; Samuel Evan Carstensen; Dylan Nicole Deal
Journal:  Hand (N Y)       Date:  2016-05-03

Review 2.  [Primary intervention in Dupuytren's disease].

Authors:  U S Vesper; I M Mehling; A Arsalan-Werner; M Sauerbier
Journal:  Orthopade       Date:  2017-04       Impact factor: 1.087

Review 3.  [Percutaneous needle aponeurotomy for Dupuytren's contracture].

Authors:  J Oppermann; F Unglaub; L P Müller; S Löw; P Hahn; C K Spies
Journal:  Orthopade       Date:  2017-04       Impact factor: 1.087

4.  Dupuytren Disease Management Trends: A Survey of Hand Surgeons.

Authors:  Logan Carr; Brett Michelotti; Morgan Brgoch; Randy Hauck; John Ingraham
Journal:  Hand (N Y)       Date:  2018-07-25

5.  Clinical outcomes following collagenase injections compared to fasciectomy in the treatment of Dupuytren's contracture.

Authors:  Raghuveer C Muppavarapu; Michael J Waters; Matthew I Leibman; Mark R Belsky; David E Ruchelsman
Journal:  Hand (N Y)       Date:  2015-06

6.  Current concepts in Dupuytren's disease.

Authors:  Steven Lo; Mark Pickford
Journal:  Curr Rev Musculoskelet Med       Date:  2013-03

Review 7.  Dupuytren's disease: current state of the art.

Authors:  Mark Henry
Journal:  Hand (N Y)       Date:  2014-03

8.  Needle aponeurotomy for Dupuytren contracture: Effectiveness of postoperative night extension splinting.

Authors:  Louisa Tam; Yin-Yin Chung
Journal:  Plast Surg (Oakv)       Date:  2016       Impact factor: 0.947

Review 9.  Collagenase Treatment in Dupuytren Contractures: A Review of the Current State Versus Future Needs.

Authors:  Ilse Degreef
Journal:  Rheumatol Ther       Date:  2016-02-03

10.  Dupuytren's Contracture - Current Concepts.

Authors:  Agneish Dutta; Gihan Jayasinghe; Saurabh Deore; Karim Wahed; Kavynash Bhan; Nik Bakti; Bijayendra Singh
Journal:  J Clin Orthop Trauma       Date:  2020-04-15
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.